Genome-wide screen for Mycobacterium tuberculosis genes that regulate host immunity

PLoS ONE

Volumn 5, Issue 12, 2010, Pages 1-14

  Beaulieu, Aimee M ^a   Rath, Poonam ^a   Imhof, Marianne ^a   Siddall, Mark E ^b   Roberts, Julia ^a   Schnappinger, Dirk ^a   Nathan, Carl F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b DIVISION OF INVERTEBRATE ZOOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SCREENING; HOST PATHOGEN INTERACTION; HOST RESISTANCE; IMMUNOREGULATION; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; MACROPHAGE FUNCTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROMOTER REGION; REPORTER GENE; ROBOTICS; RV0431 GENE; TRANSPOSON; WILD TYPE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 78650726487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015120     Document Type: Article

References (74)

1. Kaufmann SH (2006) Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol 6: 699-704.
2. WHO (2007) "Tuberculosis": World Health Organization Fact Sheet.
3. Bandera A, Gori A, Catozzi L, Degli Esposti A, Marchetti G, et al. (2001) Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol 39: 2213-2218.
4. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Afonso O, et al. (2001) Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med 163: 717-720.
5. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, et al. (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 341: 1174-1179.
6. Wolf AJ, Linas B, Trevejo-Nunez GJ, Kincaid E, Tamura T, et al. (2007) Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 179: 2509-2519.
7. Gallegos AM, Pamer EG, Glickman MS (2008) Delayed protection by ESAT-6- specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med 205: 2359-2368.
8. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, et al. (2008) ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes 10.1073/pnas.0801496105. Proceedings of the National Academy of Sciences 105: 10961-10966.
9. Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, et al. (2008) Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 205: 105-115.
10. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ (2001) The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 193: 271-280.
11. Gonzalez-Juarrero M, Kingry LC, Ordway DJ, Henao-Tamayo M, Harton M, et al. (2009) Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. Am J Respir Cell Mol Biol 40: 398-409.
12. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, et al. (2001) Reprogramming of the macrophage transcriptome in response to interferongamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194: 1123-1140.
13. Gill WP, Harik NS, Whiddon MR, Liao RP, Mittler JE, et al. (2009) A replication clock for Mycobacterium tuberculosis. Nat Med 15: 211-214.
14. Dannenberg AM, Jr., Collins FM (2001) Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (Edinb) 81: 229-242.
15. Martinez-Pomares L, Gordon S (2007) Antigen presentation the macrophage way. Cell 131: 641-643.
16. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, et al. (2008) Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28: 271-284.
17. Chen M, Divangahi M, Gan H, Shin DS, Hong S, et al. (2008) Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med 205: 2791-2801.
18. Kumar D, Nath L, Kamal MA, Varshney A, Jain A, et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140: 731-743.
19. Tobin DM, Vary JC, Jr., Ray JP, Walsh GS, Dunstan SJ, et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140: 717-730.
20. Chen ZW (2005) Immune regulation of gammadelta T cell responses in mycobacterial infections. Clin Immunol 116: 202-207.
21. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM (2008) Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog 4: e1000239.
22. Dietrich J, Doherty TM (2009) Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. Apmis 117: 440-457.
23. Beaulieu AM (2009) Identification of Genes in Mycobacterium tuberculosis that Regulate Host Immunity [Doctoral Dissertation]. New York: Cornell University.
24. Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S (2008) A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat Med 14: 849-854.
25. Darwin KH, Ehrt S, Gutierrez-Ramos JC, Weich N, Nathan CF (2003) The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302: 1963-1966.
26. Shimono N, Morici L, Casali N, Cantrell S, Sidders B, et al. (2003) Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci U S A 100: 15918-15923.
27. Dao DN, Sweeney K, Hsu T, Gurcha SS, Nascimento IP, et al. (2008) Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4: e1000081.
28. Uchida Y, Casali N, White A, Morici L, Kendall LV, et al. (2007) Accelerated immunopathological response of mice infected with Mycobacterium tuberculosis disrupted in the mce1 operon negative transcriptional regulator. Cell Microbiol 9: 1275-1283.
29. Daffe M, Draper P (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39: 131-203.
30. Beatty WL, Rhoades ER, Ullrich HJ, Chatterjee D, Heuser JE, et al. (2000) Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1: 235-247.
31. Jozefowski S, Sobota A, Kwiatkowska K (2008) How Mycobacterium tuberculosis subverts host immune responses. Bioessays 30: 943-954.
32. Guenin-Mace L, Simeone R, Demangel C (2009) Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression. Transbound Emerg Dis 56: 255-268.
33. Hunter RL, Olsen MR, Jagannath C, Actor JK (2006) Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 36: 371-386.
34. Ryll R, Kumazawa Y, Yano I (2001) Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids-a review. Microbiol Immunol 45: 801-811.
35. Reed MB, Domenech P, Manca C, Su H, Barczak AK, et al. (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431: 84-87.
36. Cox JS, Chen B, McNeil M, Jacobs WR, Jr. (1999) Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79-83.
37. Converse SE, Mougous JD, Leavell MD, Leary JA, Bertozzi CR, et al. (2003) MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc Natl Acad Sci U S A 100: 6121-6126.
38. Domenech P, Reed MB, Dowd CS, Manca C, Kaplan G, et al. (2004) The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis. J Biol Chem 279: 21257-21265.
39. Gilleron M, Stenger S, Mazorra Z, Wittke F, Mariotti S, et al. (2004) Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 199: 649-659.
40. Trivedi OA, Arora P, Sridharan V, Tickoo R, Mohanty D, et al. (2004) Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature 428: 441-445.
41. Rousseau C, Winter N, Pivert E, Bordat Y, Neyrolles O, et al. (2004) Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell Microbiol 6: 277-287.
42. Waddell SJ, Chung GA, Gibson KJ, Everett MJ, Minnikin DE, et al. (2005) Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv. Lett Appl Microbiol 40: 201-206.
43. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C (1999) Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34: 257-267.
44. Hisert KB, Kirksey MA, Gomez JE, Sousa AO, Cox JS, et al. (2004) Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening. Infect Immun 72: 5315-5321.
45. Rao A, Ranganathan A (2004) Interaction studies on proteins encoded by the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Mol Genet Genomics 272: 571-579.
46. Daniel J, Deb C, Dubey VS, Sirakova TD, Abomoelak B, et al. (2004) Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J Bacteriol 186: 5017-5030.
47. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43: 717-731.
48. Singh A, Gupta R, Vishwakarma RA, Narayanan PR, Paramasivan CN, et al. (2005) Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol 187: 4173-4186.
49. Andersen CS, Agger EM, Rosenkrands I, Gomes JM, Bhowruth V, et al. (2009) A simple mycobacterial monomycolated glycerol lipid has potent immunostimulatory activity. J Immunol 182: 424-432.
50. Guillemard E, Geniteau-Legendre M, Kergot R, Lemaire G, Gessani S, et al. (1998) Simultaneous production of IFN-gamma, IFN-alpha/beta and nitric oxide in peritoneal macrophages from TDM-treated mice. J Biol Regul Homeost Agents 12: 106-111.
51. Guidry TV, Hunter RL, Jr., Actor JK (2007) Mycobacterial glycolipid trehalose 6,69-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes. Microbiology 153: 3360-3369.
52. Welsh KJ, Abbott AN, Hwang SA, Indrigo J, Armitige LY, et al. (2008) A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,69- dimycolate induced granulomatous response. Microbiology 154: 1813-1824.
53. Yamagami H, Matsumoto T, Fujiwara N, Arakawa T, Kaneda K, et al. (2001) Trehalose 6,69-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect Immun 69: 810-815.
54. Cheruvu M, Plikaytis BB, Shinnick TM (2007) The acid-induced operon Rv3083-Rv3089 is required for growth of Mycobacterium tuberculosis in macrophages. Tuberculosis (Edinb) 87: 12-20.
55. Brodin P, Majlessi L, Marsollier L, de Jonge MI, Bottai D, et al. (2006) Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun 74: 88-98.
56. Simeone R, Bottai D, Brosch R (2009) ESX/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 12: 4-10.
57. Stanley SA, Raghavan S, Hwang WW, Cox JS (2003) Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A 100: 13001-13006.
58. Singh KK, Dong Y, Patibandla SA, McMurray DN, Arora VK, et al. (2005) Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) protein during incipient and clinical tuberculosis. Infect Immun 73: 5004-5014.
59. Malen H, Softeland T, Wiker HG (2008) Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins. Scand J Immunol 67: 245-252.
60. Chakhaiyar P, Nagalakshmi Y, Aruna B, Murthy KJ, Katoch VM, et al. (2004) Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis. J Infect Dis 190: 1237-1244.
61. Delogu G, Brennan MJ (2001) Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect Immun 69: 5606-5611.
62. Tundup S, Pathak N, Ramanadham M, Mukhopadhyay S, Murthy KJ, et al. (2008) The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response. PLoS ONE 3: e3586.
63. Choudhary RK, Mukhopadhyay S, Chakhaiyar P, Sharma N, Murthy KJ, et al. (2003) PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong Bcell response. Infect Immun 71: 6338-6343.
64. Basu S, Pathak SK, Banerjee A, Pathak S, Bhattacharyya A, et al. (2007) Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha. J Biol Chem 282: 1039-1050.
65. Balaji KN, Goyal G, Narayana Y, Srinivas M, Chaturvedi R, et al. (2007) Apoptosis triggered by Rv1818c, a PE family gene from Mycobacterium tuberculosis is regulated by mitochondrial intermediates in T cells. Microbes Infect 9: 271-281.
66. Sassetti CM, Rubin EJ (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100: 12989-12994.
67. D'Orazio M, Folcarelli S, Mariani F, Colizzi V, Rotilio G, et al. (2001) Lipid modification of the Cu,Zn superoxide dismutase from Mycobacterium tuberculosis. Biochem J 359: 17-22.
68. Piddington DL, Fang FC, Laessig T, Cooper AM, Orme IM, et al. (2001) Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun 69: 4980-4987.
69. Lazarevic V, Margot P, Soldo B, Karamata D (1992) Sequencing and analysis of the Bacillus subtilis lytRABC divergon: a regulatory unit encompassing the structural genes of the N-acetylmuramoyl-L-alanine amidase and its modifier. J Gen Microbiol 138: 1949-1961.
70. Hubscher J, Luthy L, Berger-Bachi B, Stutzmann Meier P (2008) Phylogenetic distribution and membrane topology of the LytR-CpsA-Psr protein family. BMC Genomics 9: 617.
71. Andersen P, Doherty TM (2005) The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3: 656-662.
72. Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, et al. (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70: 672-678.
73. Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC (2009) Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol 21: 331-338.
74. Sampson SL, Dascher CC, Sambandamurthy VK, Russell RG, Jacobs WR, Jr., et al. (2004) Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs. Infect Immun 72: 3031-3037.